Search

Joseph Pape

Examiner (ID: 18031, Phone: (571)272-6664 , Office: P/3612 )

Most Active Art Unit
3612
Art Unit(s)
2899, 3102, 3612
Total Applications
4170
Issued Applications
3665
Pending Applications
184
Abandoned Applications
378

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16824261 [patent_doc_number] => 20210139554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS [patent_app_type] => utility [patent_app_number] => 17/065395 [patent_app_country] => US [patent_app_date] => 2020-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -125 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065395 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/065395
Interleukin-2 muteins for the expansion of T-regulatory cells Oct 6, 2020 Issued
Array ( [id] => 16727850 [patent_doc_number] => 20210094997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS [patent_app_type] => utility [patent_app_number] => 17/063566 [patent_app_country] => US [patent_app_date] => 2020-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063566 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/063566
Interleukin-2 muteins for the expansion of T-regulatory cells Oct 4, 2020 Issued
Array ( [id] => 18685195 [patent_doc_number] => 11780913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-10 [patent_title] => IL-1b neutralizing human monoclonal antibodies [patent_app_type] => utility [patent_app_number] => 17/061194 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 17 [patent_no_of_words] => 10130 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061194 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/061194
IL-1b neutralizing human monoclonal antibodies Sep 30, 2020 Issued
Array ( [id] => 18492272 [patent_doc_number] => 11697683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-11 [patent_title] => Anti-IL31 antibodies for veterinary use [patent_app_type] => utility [patent_app_number] => 17/039495 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 16300 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17039495 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/039495
Anti-IL31 antibodies for veterinary use Sep 29, 2020 Issued
Array ( [id] => 18004987 [patent_doc_number] => 20220363753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => ANTI-TIRC7 ANTIGEN BINDING PROTEINS [patent_app_type] => utility [patent_app_number] => 17/765267 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26320 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765267 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/765267
Anti-TIRC7 antigen binding proteins Sep 29, 2020 Issued
Array ( [id] => 18413173 [patent_doc_number] => 11667706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Methods of purifying recombinant anti-abeta antibodies [patent_app_type] => utility [patent_app_number] => 17/031468 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 36782 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031468 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/031468
Methods of purifying recombinant anti-abeta antibodies Sep 23, 2020 Issued
Array ( [id] => 17958677 [patent_doc_number] => 20220339257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => METHODS TO INCREASE THE SENSITIVITY AND REVERSING THE RESISTANCE TO DRUGS [patent_app_type] => utility [patent_app_number] => 17/761461 [patent_app_country] => US [patent_app_date] => 2020-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14872 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761461 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761461
METHODS TO INCREASE THE SENSITIVITY AND REVERSING THE RESISTANCE TO DRUGS Sep 16, 2020 Abandoned
Array ( [id] => 18970297 [patent_doc_number] => 20240050389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS [patent_app_type] => utility [patent_app_number] => 18/245157 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26477 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245157 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/245157
TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS Sep 14, 2020 Pending
Array ( [id] => 16750946 [patent_doc_number] => 20210102955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => Methods to Determine the Presence of an Antibody that Binds Modified Human Thymic Stromal Lymphopoietin (TSLP) [patent_app_type] => utility [patent_app_number] => 17/020325 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12304 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020325 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/020325
Methods to Determine the Presence of an Antibody that Binds Modified Human Thymic Stromal Lymphopoietin (TSLP) Sep 13, 2020 Abandoned
Array ( [id] => 18211359 [patent_doc_number] => 20230057622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => Recombinant Human Neuregulin Derivatives and Use Thereof [patent_app_type] => utility [patent_app_number] => 17/642855 [patent_app_country] => US [patent_app_date] => 2020-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642855 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/642855
Recombinant Human Neuregulin Derivatives and Use Thereof Sep 13, 2020 Pending
Array ( [id] => 18180915 [patent_doc_number] => 20230041644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/753692 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753692 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/753692
METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS Sep 10, 2020 Pending
Array ( [id] => 18180915 [patent_doc_number] => 20230041644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/753692 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753692 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/753692
METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS Sep 10, 2020 Pending
Array ( [id] => 18180915 [patent_doc_number] => 20230041644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/753692 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753692 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/753692
METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS Sep 10, 2020 Pending
Array ( [id] => 18180915 [patent_doc_number] => 20230041644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/753692 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753692 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/753692
METHODS AND COMPOSITIONS FOR TREATING STAPHYLOCOCCAL INFECTIONS Sep 10, 2020 Pending
Array ( [id] => 16657465 [patent_doc_number] => 20210054101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => ANTIBODIES TO MATRIX METALLOPROTEINASE 9 [patent_app_type] => utility [patent_app_number] => 17/017491 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/017491
Antibodies to matrix metalloproteinase 9 Sep 9, 2020 Issued
Array ( [id] => 16525256 [patent_doc_number] => 20200399336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => IL-21 (HETERODIMERIC FC-FUSED IL-21) FUSED TO IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION HETERODIMER (HETERODIMERIC FC), AND PHARMACEUTICAL COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 17/015875 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6414 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015875 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/015875
IL-21 (heterodimeric Fc-fused IL-21) fused to immunoglobulin heavy chain constant region heterodimer (heterodimeric Fc), and pharmaceutical composition comprising same Sep 8, 2020 Issued
Array ( [id] => 16621531 [patent_doc_number] => 20210040184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => ANTI-HIV ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/015287 [patent_app_country] => US [patent_app_date] => 2020-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015287 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/015287
ANTI-HIV ANTIBODIES Sep 8, 2020 Abandoned
Array ( [id] => 17897053 [patent_doc_number] => 20220306715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => CHIMERIC PROTEINS IN AUTOIMMUNITY [patent_app_type] => utility [patent_app_number] => 17/638925 [patent_app_country] => US [patent_app_date] => 2020-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81583 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -94 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638925 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/638925
CHIMERIC PROTEINS IN AUTOIMMUNITY Aug 27, 2020 Abandoned
Array ( [id] => 16941073 [patent_doc_number] => 11053294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-06 [patent_title] => Masked cytokine polypeptides [patent_app_type] => utility [patent_app_number] => 17/002742 [patent_app_country] => US [patent_app_date] => 2020-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 132 [patent_no_of_words] => 157122 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002742 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/002742
Masked cytokine polypeptides Aug 24, 2020 Issued
Array ( [id] => 16525258 [patent_doc_number] => 20200399338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => IL-15 Conjugates and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/001965 [patent_app_country] => US [patent_app_date] => 2020-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -88 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001965 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/001965
IL-15 conjugates and uses thereof Aug 24, 2020 Issued
Menu